NewGenIvf Group Ltd Files November 2024 6-K Report
Ticker: NIVFW · Form: 6-K · Filed: Nov 22, 2024 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Nov 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
TL;DR
NewGenIvf Group Ltd (formerly ASPAC I Mini Acquisition Corp.) filed its November 6-K, including a press release. Check it out.
AI Summary
NewGenIvf Group Limited filed a Form 6-K on November 22, 2024, reporting for the month of November 2024. The filing includes a press release as Exhibit 99.1. The company, formerly known as ASPAC I Mini Acquisition Corp. until June 14, 2023, is incorporated in D8 and has principal executive offices in Bangkok, Thailand.
Why It Matters
This filing provides an update on the company's activities and regulatory disclosures for November 2024, which is important for investors to stay informed about the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — This is a routine 6-K filing which typically contains press releases or other periodic information, not usually indicative of significant immediate risk.
Key Players & Entities
- NewGenIvf Group Limited (company) — Registrant
- ASPAC I Mini Acquisition Corp. (company) — Former company name
- Wing Fung Alfred Siu (person) — Signatory for the filing
- November 22, 2024 (date) — Filing date
- 001-42004 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers filed with the SEC to provide information that the issuer would be required to make public pursuant to the laws of its home country or that it may otherwise make public.
When was NewGenIvf Group Limited previously known by another name?
NewGenIvf Group Limited was formerly known as ASPAC I Mini Acquisition Corp. until June 14, 2023.
What is included as an exhibit in this 6-K filing?
Exhibit 99.1, a press release, is included in this 6-K filing.
Where are NewGenIvf Group Limited's principal executive offices located?
The company's principal executive offices are located at 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke), Khlong Toei Nuea Sub-district, Watthana District, Bangkok 10110, Thailand.
Who signed this Form 6-K on behalf of NewGenIvf Group Limited?
Wing Fung Alfred Siu signed the Form 6-K on behalf of NewGenIvf Group Limited.
Filing Stats: 159 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-11-22 07:00:02
Filing Documents
- ea0222239-6k_newgen.htm (6-K) — 10KB
- ea022223901ex99-1_newgen.htm (EX-99.1) — 10KB
- 0001213900-24-101207.txt ( ) — 21KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-42004 NEWGENIVF GROUP LIMITED 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press release 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 22, 2024 NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director 2